Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.

Atadja, Peter and Gao, Lin and Kwon, Paul and Trogani, Nancy and Walker, Heather and Hsu, Meier and Yeleswarapu, N. and Chandramouli, Nagarajan and Perez, Lawrence and Versace, Richard and Wu, Arthur and Sambucetti, Lidia and Lassota, Piotr and Cohen, Dalia and Bair, Kenneth and Wood, Alexander and Remiszewski, Stacy (2004) Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824. Cancer Research, 64 (2). pp. 689-695. ISSN 0008-5472

Abstract

We have synthesized a histone deacetylase inhibitor, NVP-LAQ824, a cinnamic hydroxamic acid, that inhibited in vitro enzymatic activities and transcriptionally activated the p21 promoter in reporter gene assays. NVP-LAQ824 selectively inhibited growth of cancer cell lines at submicromolar levels after 48-72 h of exposure, whereas higher concentrations and longer exposure times were required to retard the growth of normal dermal human fibroblasts. Flow cytometry studies revealed that both tumor and normal cells arrested in the G(2)-M phase of the cell cycle after compound treatment. However, an increased sub-G(1) population at 48 h (reminiscent of apoptotic cells) was observed only in the cancer cell line. Annexin V staining data supported our hypothesis that NVP-LAQ824 induced apoptosis in tumor and transformed cells but not in normal cells. Western blotting experiments showed an increased histone H3 and H4 acetylation level in NVP-LAQ824-treated cancer cells, suggesting that the likely in vivo target of NVP-LAQ824 was histone deacetylase(s). Finally, NVP-LAQ824 exhibited antitumor effects in a xenograft animal model. Together, our data indicated that the activity of NVP-LAQ824 was consistent with its intended mechanism of action. This novel histone deacetylase inhibitor is currently in clinical trials as an anticancer agent.

Item Type: Article
Related URLs:
Additional Information: author can archive post-print (ie final draft post-refereeing); Authors final version may be deposited on institutional website/ repository if required by institution
Related URLs:
Date Deposited: 14 Dec 2009 13:54
Last Modified: 31 Jan 2013 01:06
URI: https://oak.novartis.com/id/eprint/779

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.